Kyn Capital Group (OTCMKTS:KYNC) Stock Sees Sell-Off on Profit Booking: Now What?

August 5, 2021

Kyn Capital Group (OTCMKTS:KYNC) fell 22% in profit booking. Recently the company announced ArtistRelations.com as an Entertainment and Music industry consultant. The endorsement leader with musicians for over 20 years will be discussing the anticipated KoinFold app. Notably, ArtistRelations.com, which focuses on Artist Relations, handling of endorsements for several musical gear brands, and acquiring deliverables including posed photography, video testimonials, and video content, has a database of almost 14,000 artists….

Read More >>

ProBility Media Corp (OTCMKTS:PBYA) Stock Falls After The Recent Jump: A Good Buy?

August 5, 2021

ProBility Media Corp (OTCMKTS:PBYA) is down 20% in a week. The company’s subsidiary North American Crane Bureau Group has commenced a multi-phase contract with Westlake Petrochemical (NYSE: WLK) and Dominion Energy (NYSE: D). Notably, Westlake Petrochemical programs will commence in August and comprise several crane operator training initiatives. The specialized training seeks to reinforce participants’ knowledge and prepare mobile crane operators for National Centre for Construction Education and Research (NCCER)…

Read More >>

Would Vinco Ventures, Inc. (NASDAQ:BBIG) Be Able To Ride On Lomotif?

August 4, 2021

Vinco Ventures, Inc. (NASDAQ: BBIG), selective acquisitions company primarily focusing on digitalmedia and content technologies is looking forward to close its merger deal with Lomotif. Lomotif, which is similar to TikTok app is a developer of a social video application designed to make music videos with friends. The company’s application offers instant edits with clips, stickers, filters and titles, adding music tracks to video and a reaction GIF to the…

Read More >>

Beyondspring Inc (NASDAQ:BYSI) Stock Soars: H.C. Wainwright Upgardes With $100 PT

August 4, 2021

Shares of Beyondspring Inc (NASDAQ:BYSI) soared 170% to $26.06 after the company announced positive topline data of DUBLIN-3 trial in plinabulin in combination with docetaxel (DP) to treat 2nd and 3rd line NSCLC (EGFR wild type) compared to docetaxel alone (D) (n=559). H.C. Wainwright upgrades BYSI to Buy from Neutral and sets target price at $100. Analyst Joseph Pantginis said, “Dublin-3 provides some beautiful summer fireworks with endpoints met, representing…

Read More >>

BeyondSpring (NASDAQ:BYSI) Stock All Set To Gap Up: How to Trade Now?

August 4, 2021

BeyondSpring (NASDAQ:BYSI) is the biggest gainer in the pre-market session after announcing positive topline data of DUBLIN-3 trial in plinabulin in combination with docetaxel (DP) to treat 2nd and 3rd line NSCLC (EGFR wild type) compared to docetaxel alone (D) (n=559). The combination met the primary endpoint of increasing overall survival (OS) (mean OS, p=0.03; OS log rank: p <0.04). The study also met key secondary endpoints, including significantly improving…

Read More >>

Is Mustang Bio Inc (NASDAQ:MBIO) stock A Good Buy After The Recent Fall?

August 3, 2021

The new week did not start off on a particularly great note for the Mustang Bio Inc (NASDAQ:MBIO) stock. The company, which is involved in deploying the medical advancements of gene and cell therapies into actual therapies, saw its stock actually decline by as much as 4% yesterday amidst a bit of a selloff. However, in this regard, it ought to be noted that the company actually made a positive…

Read More >>

Is Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Stock a Better Bet Now After The Recent Fall?

August 3, 2021

Based in New York, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP). is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800.However, recently the entire company is appearing quite fragile. The company has recently reported that it would not register any new patients with fibromyalgia with respect…

Read More >>

GNCC Capital Inc. (OTCMKTS:GNCP) Stock Continues to Move in a range: What Next?

August 3, 2021

GNCC Capital Inc. (OTCMKTS:GNCP) moved in range after the company confirmed that its directors had agreed to enter material discussions. The company said a credible Corporate Finance Company had approached it to raise the funding necessary to effect an option regarding the Lithium Exploration Properties. The raise will offer additional funding to allow GNCC Capital to purchase an established company generating cash flow and revenue. Most importantly, GNCCDirectors wish to…

Read More >>

Vaxart Inc (NASDAQ:VXRT) Stock Moves Toward $8 After The News: How Far Can it Go?

August 2, 2021

Clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, Vaxart (NASDAQ:VXRT) saw its shares surge by almost 10% after it announced FDA clearing investigational new Drug application for an S-only oral tablet SARS-CoV-2 vaccine candidate. Andrei Floroiu, Vaxart’s CEO, said that along with S-only and S+N constructs comprise of its COVID-19 vaccine candidate portfolio. The clinical trial will enable the firm to compare…

Read More >>

Is OPKO Health Inc (NASDAQ:OPK) ready To Recover After The Recent Fall?

August 2, 2021

The previous week ended on a weak note for OPKO Health Inc (NASDAQ:OPK) as the stock slid by as much as 9% and today the company’s shareholders would be hoping for a quick recovery. Last week the company announced its financial results for the quarter that ended on June 30, 2021 and that might have been one of the reasons behind the decline. In the second quarter, the company managed…

Read More >>